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Making Progress
on Breast Cancer
For the last two years, scientists across the
country have been working together in a
highly collaborative effort to uncover the
links between exposure to environmental
pollutants, puberty, and development of
breast cancer. On 10–11 November 2005
the Breast Cancer and the Environment
Research Centers (BCERCs), a joint effort of
the NIEHS and the National Cancer
Institute, came together in Michigan to share
what they have accomplished to date. Each
center reported on advances made over the
past year in their two research components:
1) research on the basic biology of mammary
gland development, and 2) epidemiologic
studies of how environmental factors affect
puberty in girls.
The impetus for creation of the centers
came from appeals from advocates, who
urged the NIH to support a more compre-
hensive approach to research on the environ-
mental causes of breast cancer. “We wanted a
research approach that focused on environ-
mental causes, and we wanted more involve-
ment from the advocates’ perspective,” said
Dale Eastman, vice president of the Alamo
Breast Cancer Foundation.
“The centers represent a great opportuni-
ty to conduct transdisciplinary science to
explore the problem of breast cancer from
many different perspectives, including the
valuable perspective of [breast cancer sur-
vivor] advocates,” said Robert Hiatt, principal
investigator for the BCERC at the University
of California, San Francisco, which collabo-
rates with Lawrence Berkeley National
Laboratory and serves as the coordinating
center for the BCERC network. The other
three centers are housed at the Fox Chase
Cancer Center in Philadelphia (which collab-
orates with Mount Sinai School of Medicine
in New York and the University of Alabama
at Birmingham), the University of Cincinnati
in Ohio (which collaborates with Cincinnati
Children’s Hospital Medical Center), and
Michigan State University in East Lansing.
Three important features characterize the
BCERC program. First, the four centers
work together as a network in which experi-
mental methods are coordinated in order to
maximize the pooling and comparison of the
data generated. Second, to allow adequate
time to track the subjects and collect compre-
hensive information on the onset and
progress of puberty, the BCERCs will be
funded for seven years, an unusually long
time, given that most NIH grants are funded
for a maximum of five years. Third, represen-
tatives of breast cancer survivor advocacy
organizations are integral members of the
centers. The advocate members participate in
many aspects of the decision-making process-
es, collaborate with the Community
Outreach and Translation Cores of the cen-
ters, and added much to the discussion at the
annual meeting. 
Basic Biology Advances
Many of the significant advances of the past
year were made in basic biology studies that
use laboratory rodents and cell cultures as
models. “This is not surprising, as the human
studies are prospective and will yield their
most valuable information over time,” said
Les Reinlib, a program official at the NIEHS
who directs the BCERC program. 
At the November meeting, Deborah J.
Clegg, an assistant professor of psychiatry at
the University of Cincinnati, described the
insights of her team into understanding the
links between obesity, body fat distribution,
and postmenopausal breast cancer. Based on
her observations of how fat distributes in vari-
ous body regions, Clegg hypothesized that
women who accumulate fat in the upper
body—the pattern typically seen in men—
would have a greater breast cancer risk than
women who accumulate fat in the lower body
and thighs. Her team is the first to directly
test this idea in humans. Clegg’s hypothesis is
supported by reports linking insulin resis-
tance, increased recurrence of tumors, and
lower survival in obese breast cancer patients
with the male pattern of fat distribution.
Clegg suggested that body fat distribution
may be a better measure than body mass
index in determining breast cancer risk.
The team lead by Jose Russo, director of
the Fox Chase Cancer Center BCERC and a
senior member of the Fox Chase Medical
Science Division, is studying the impact of
endocrine disruptors on mammary gland
development in rats. In this study, animals are
exposed at different times in development to
environmental pollutants of concern, includ-
ing bisphenol A and butyl benzyl phthalate.
Bisphenol A is an estrogenic substance that is
used in the production of some plastics and in
food container coatings, while butyl benzyl
phthalate is used to plasticize polyvinyl chlo-
ride and other polymers. These investigators
are finding that, depending on the time of
exposure and the age of the young rats upon
examination, different genes are up- or down-
regulated by the exposures. 
Their studies demonstrate that these
compounds modify the genomic profile of
the rat mammary gland and that these
changes are age-specific, indicating windows
of vulnerability in the development of the
gland. “Interestingly, we are finding that
some of these genes, such as glutamic decar-
boxylase 1, that are affected by exposure to
estrogenic plasticizers have been implicated in
other diseases such as autism, bipolar disor-
ders, schizophrenia, diabetes, and cancer,”
said Russo. “So there is an opportunity here
to investigate not only how these compounds
affect the genomic profile of the mammary
gland but also how other organs are affected,
explaining other diseases as well.”
At Michigan State University, center
director and physiology professor Sandra
Haslam is conducting studies in both rats
and mice. Her work focuses on the study of
the normal mammary gland in order to
understand how progesterone, a hormone
secreted in the second half of the menstrual
cycle, is involved in breast development and
perhaps in carcinogenesis. She said, “For pre-
vention methods to be produced, we must
understand the normal developmental
process.” To do this, her team is defining the
architecture and timing of two forms of
progesterone receptors (PR-A and PR-B) as
they are expressed on mammary gland cells
from rats and mice. From the patterns of
expression of these receptors and their colo-
calization with proliferation markers,
Haslam infers the roles of the receptors on
cell growth and maturation. 
Haslam showed that the rat model is
more similar than the mouse model to the
human breast in terms of the patterns of
receptors expressed. However, the mouse
model exhibits novel differences that may
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ences in the functional roles of PR-A and
PR-B. Each animal model may provide
information about certain aspects of the
human condition but not others, given the
many differences that exist among the
species. Said Haslam, “Ideally, we would
have access to human breast tissues from dif-
ferent times in development, but it is
extremely difficult [to get breast tissue from
women who do not have cancer].”
Human cells have been used in the labo-
ratory to try to study some aspects of carcino-
genesis that may be uniquely human and thus
are difficult to study in rodents. Paul Yaswen,
a staff scientist at the Lawrence Berkeley
National Laboratory, is using human breast
epithelial cells to define molecular events and
cellular characteristics that allow tumor pro-
gression. When mammary cells become
exposed to a carcinogen, their genomic tumor
suppression pathways fail, and the cells
become immortalized, or able to reproduce
without proper controls. At the meeting,
Yaswen presented work on two main tumor
suppression pathways involved in blocking
indefinite proliferation of breast cells derived
from normal human tissue. These tumor sup-
pression pathways represent a gauntlet that
carcinogen-exposed cells must overcome in
order to acquire cancerous properties. 
Listening and Learning
In the closing session, Gwen Collman, chief
of the NIEHS Susceptibility and Population
Health Branch, presented a framework upon
which the results from the different
BCERCs will fill in the gaps of scientific
understanding about mammary gland devel-
opment and breast cancer in the context of
likely environmental carcinogens. “It was
always our intention that [the BCERC pro-
gram] would spark dialogue between labora-
tories, scientists of different disciplines, and
advocates,” said Collman. 
Although the data presented at the scien-
tific sessions reflect advances in uncovering
the link between environmental exposures
and breast cancer, there’s still a long way to
go before a cure for breast cancer is found.
“We have been with the scientists from the
beginning, and we have seen the progress, but
what do we tell our communities of women
who are dying of breast cancer right now?”
asked Virginia Regnante, president of the
West Islip Breast Cancer Coalition. She sug-
gested that scientists should concentrate on
testing the many chemicals that are likely to
cause cancer in communities with high rates
of breast cancer. “It is an inspiration to have
the advocates not be afraid to tell us what
they need from us scientists,” answered Irma
Russo, an investigator in the Fox Chase
BCERC. –Luz Claudio
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Headliners Breast Cancer
NIEHS-Supported Research
Decreased Melatonin Production Linked to Light Exposure
Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, et al. 2005. Cancer
Res 65(23):11174–11184.
The incidence of breast cancer is up to fives times higher in women living in
industrialized nations compared to those living in developing countries, and
female night shift workers have particularly high rates of the disease. Given
that Western nations have
become “24-hour societies,”
with more people awake
around the clock, one
hypothesis holds that night-
time exposure to artificial
light suppresses the noctur-
nal production of melatonin.
This hormone, produced by
the pineal gland, helps regu-
late the body’s circadian
rhythm and immune func-
tion, and also suppresses
tumor growth. Now NIEHS
grantees David E. Blask and
George C. Brainard and their
colleagues have confirmed
that ocular exposure to
bright artificial light at night
inhibits the production of
melatonin, which in turn
may lead to an increased risk
of developing breast cancer. 
The researchers implant-
ed human breast cancer cells
into female laboratory mice,
then transferred the malig-
nant tumors that formed to
female rats for continued
development. They then col-
lected blood from several
healthy premenopausal vol-
unteers under three differ-
ent conditions: during the day, during the night following two hours of com-
plete darkness, and during the night following 90 minutes of exposure to bright
fluorescent light. 
Next, they infused the collected blood directly through the developing
tumors. Melatonin-rich blood collected following complete darkness slowed
the growth of cancer tumors, while melatonin-depleted blood collected from
volunteers exposed to both daylight and bright fluorescent light stimulated
tumor growth. 
The team also exposed tumor-bearing rats to varying intensities of light
during the darkness phase of an alternating 12-hour light/12-hour dark cycle.
They found that the extent to which melatonin production was suppressed
depended on the magnitude of the light intensity that the rats were exposed
to during the dark phase.
The authors say these results establish a role for the natural, nocturnal
production of melatonin as a preventive agent in human disease. They also
emphasize the risks of extensive exposure to bright artificial light at night,
and point to the possibility that preserving the integrity of the circadian mela-
tonin signal could help prevent breast cancer. –Tanya Tillett